adenosine 5'-triphosphate


Also found in: Dictionary, Thesaurus, Encyclopedia, Wikipedia.

a·den·o·sine 5'-tri·phos·phate (ATP),

(ă-den'ō-sēn trī-fos'fāt),
Adenosine with triphosphoric acid esterified at its 5' position; immediate precursor of adenine nucleotides in RNA; the primary energy currency of a cell.

adenosine triphosphate

An adenosine with 3 high-energy phosphates, which is required for RNA synthesis and present in all living cells; ATP is a key energy source which drives many metabolic processes, including those involving motor proteins, movement of molecules against concentration gradients and the synthesis of proteins, nucleic acids and other molecules.

a·den·o·sine 5'-tri·phos·phate

(ATP) (ă-den'ō-sēn trī-fos'fāt)
Adenosine (5) pyrophosphate; adenosine with triphosphoric acid esterfied at its 5' position; immediate precursor of adenine nucleotides in RNA. The primary energy currency of a cell.

a·den·o·sine 5'-tri·phos·phate

(ATP) (ă-denŏ-sēn trī-fosfāt)
Adenosine with triphosphoric acid esterified at its 5' position; immediate precursor of adenine nucleotides in RNA; the promary energeny of a cell.
References in periodicals archive ?
BULLETIN BOARD: DSKA) announced today that it has entered into a series of agreements to acquire exclusive worldwide rights from several inventors to develop and commercialize technologies relating to the use of adenosine 5'-triphosphate (ATP) to improve motility of human and animal sperm.
BULLETIN BOARD: DSKA) , a biotechnology company developing medical products based on adenosine 5'-triphosphate (ATP) and P2 receptor-related technologies, announced today that it has scheduled its 2008 Annual Meeting of Shareholders for 10AM (Eastern) on June 27, 2008.
OTC BB:DSKT) today announced the publication of a clinical research study showing that ATP - adenosine 5'-triphosphate - may play a significant role in asthma symptoms.
OTCBB:DSKT), a biopharmaceutical firm developing therapeutic and diagnostic products based on the biological compound adenosine 5'-triphosphate (ATP) and its cell-surface receptors, today announced that it has retained Investor Relations International, Inc.

Full browser ?